A AZN

Astrazeneca plc

DRUG MANUFACTURERS - GENERAL · HEALTHCARE

AstraZeneca PLC is a leading global biopharmaceutical company based in Cambridge, UK, renowned for its innovative research in the development of prescription medicines across critical therapeutic areas such as oncology, cardiovascular, renal, respiratory, and neuroscience. With a strong and diverse ...

$193.28

-0.88% ($1.72)

Volume 1.42M

52W High $212.71

52W Low $60.81

Market Cap $291.47B

← Back to Calendar Compare with Others →

Next Earnings Report

No earnings data available for AZN

Price Chart

EPS History: Consensus vs Actual

Last 4 quarters

Price Movement Around Earnings

Q4 2025 Feb 10, 2026

1-Day: +5.87%

Q3 2025 Sep 30, 2025

1-Day: +9.96%

Q2 2025 Jun 30, 2025

1-Day: +2.26%

Q1 2025 Mar 31, 2025

1-Day: -1.22%

Revenue & Financial Performance

Quarter	Revenue	YoY Growth	Gross Margin	Op Margin	Net Income
Q4'25	$15.50B	+4.1%	79.9%	19.2%	$2.33B
Q3'25	$15.19B	+12.0%	81.6%	23.6%	$2.53B
Q2'25	$14.46B	+11.7%	82.9%	24.3%	$2.45B
Q1'25	$13.59B	+7.2%	83.5%	27.0%	$2.92B
Q4'24	$14.89B	+23.8%	81.7%	13.7%	$1.50B
Q3'24	$13.57B	+18.0%	77.3%	15.5%	$1.43B
Q2'24	$12.94B	+13.3%	83.1%	21.2%	$1.93B
Q1'24	$12.68B	+16.6%	82.5%	24.6%	$2.18B

Historical Earnings

Last 12 quarters

Quarter	Date	Consensus	Whisper	Actual EPS	Surprise %	Result
Q4 2025	Feb 10, 2026	$2.10	$2.11	--	--	--
Q3 2025	Sep 30, 2025	$1.13	$1.12	$1.19	+4.87%	Beat
Q2 2025	Jun 30, 2025	$1.46	$1.51	$1.09	-25.90%	Missed
Q1 2025	Mar 31, 2025	$1.12	$1.16	$1.25	+11.59%	Beat
Q4 2024	Dec 31, 2024	$1.04	$1.05	$1.05	+0.84%	Met
Q3 2024	Sep 30, 2024	--	--	$0.91	--	--
Q2 2024	Jun 30, 2024	--	--	$1.24	--	--
Q1 2024	Mar 31, 2024	--	--	$1.40	--	--
Q4 2023	Dec 31, 2023	--	--	$0.62	--	--
Q3 2023	Sep 30, 2023	--	--	$0.88	--	--
Q2 2023	Jun 30, 2023	--	--	$1.17	--	--
Q1 2023	Mar 31, 2023	--	--	$1.16	--	--